Long-term Outcome in Heart Failure Patients Treated with Levothyroxine: An Observational Nationwide Cohort Study.

Conclusion: On-going and incident L-T4 treatment in patients with HF was associated with an increased risk of all-cause mortality, cardiovascular death, and MACE. Increased risk of MI was observed for on-going treatment, reduced risk was observed for incident treatment.
PMID: 30517746 [PubMed - as supplied by publisher]

Source: The Journal of Clinical Endocrinology and Metabolism - December 4, 2018 Category: Endocrinology Authors: Einfeldt MN, Olsen AS, Kristensen SL, Khalid U, Faber J, Torp-Pedersen C, Gislason GH, Selmer C Tags: J Clin Endocrinol Metab Source Type: research